316 related articles for article (PubMed ID: 19770123)
1. Equity in the distribution of community pharmacies in England: impact of regulatory reform.
Wagner A; Hann M; Noyce P; Ashcroft D
J Health Serv Res Policy; 2009 Oct; 14(4):243-8. PubMed ID: 19770123
[TBL] [Abstract][Full Text] [Related]
2. Where did all the GPs go? Increasing supply and geographical equity in England and Scotland.
Goddard M; Gravelle H; Hole A; Marini G
J Health Serv Res Policy; 2010 Jan; 15(1):28-35. PubMed ID: 19843638
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical care in community pharmacies: practice and research in Estonia.
Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
[TBL] [Abstract][Full Text] [Related]
4. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
Lee YC; Huang KH; Huang YT
Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
[TBL] [Abstract][Full Text] [Related]
5. Market dynamics of community pharmacies in Minnesota.
Schommer JC; Singh RL; Cline RR; Hadsall RS
Res Social Adm Pharm; 2006 Sep; 2(3):347-58. PubMed ID: 17138519
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the role played by community pharmacies in oral healthcare situated in a primary care trust in the north of England.
Maunder PE; Landes DP
Br Dent J; 2005 Aug; 199(4):219-23, discussion 211. PubMed ID: 16127405
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical care in community pharmacies: practice and research in Denmark.
Herborg H; Sørensen EW; Frøkjaer B
Ann Pharmacother; 2007 Apr; 41(4):681-9. PubMed ID: 17389660
[TBL] [Abstract][Full Text] [Related]
8. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
Sheridan J; Manning V; Ridge G; Mayet S; Strang J
Addiction; 2007 Nov; 102(11):1824-30. PubMed ID: 17935587
[TBL] [Abstract][Full Text] [Related]
9. The impact of private-sector provision on equitable utilisation of coronary revascularisation in London.
Mindell J; Klodawski E; Fitzpatrick J; Malhotra N; McKee M; Sanderson C
Heart; 2008 Aug; 94(8):1008-11. PubMed ID: 17693460
[TBL] [Abstract][Full Text] [Related]
10. Providing patient care through community pharmacies in the UK: policy, practice, and research.
Noyce PR
Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical care in community pharmacies: practice and research in Germany.
Eickhoff C; Schulz M
Ann Pharmacother; 2006 Apr; 40(4):729-35. PubMed ID: 16569798
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacy services in Portugal.
Costa S; Santos C; Silveira J
Ann Pharmacother; 2006 Dec; 40(12):2228-34. PubMed ID: 17148652
[TBL] [Abstract][Full Text] [Related]
13. Market factors and the availability of community pharmacies.
Doucette WR; Brooks JM; Sorofman BA; Wong H
Clin Ther; 1999 Jul; 21(7):1267-79; discussion 1266. PubMed ID: 10463523
[TBL] [Abstract][Full Text] [Related]
14. Spatial access to health care in Costa Rica and its equity: a GIS-based study.
Rosero-Bixby L
Soc Sci Med; 2004 Apr; 58(7):1271-84. PubMed ID: 14759675
[TBL] [Abstract][Full Text] [Related]
15. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
Rudholm N
Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
[TBL] [Abstract][Full Text] [Related]
16. Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012.
Schommer JC; Yusuf AA; Hadsall RS
Res Social Adm Pharm; 2014; 10(1):217-31. PubMed ID: 23669250
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study.
Bradley F; Wagner AC; Elvey R; Noyce PR; Ashcroft DM
Health Policy; 2008 Dec; 88(2-3):258-68. PubMed ID: 18468713
[TBL] [Abstract][Full Text] [Related]
18. Cutting care clusters: the creation of an inverse pharmacy care law? An area-level analysis exploring the clustering of community pharmacies in England.
Todd A; Thomson K; Kasim A; Bambra C
BMJ Open; 2018 Aug; 8(7):e022109. PubMed ID: 30068619
[TBL] [Abstract][Full Text] [Related]
19. Cross sectional study of performance indicators for English Primary Care Trusts: testing construct validity and identifying explanatory variables.
Brown C; Lilford R
BMC Health Serv Res; 2006 Jun; 6():81. PubMed ID: 16805907
[TBL] [Abstract][Full Text] [Related]
20. Private local pharmacies in low- and middle-income countries: a review of interventions to enhance their role in public health.
Smith F
Trop Med Int Health; 2009 Mar; 14(3):362-72. PubMed ID: 19207171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
